NCT03740165 2025-10-22KEYLYNK-001Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,367 enrolled 29 charts
NCT02571725 2025-05-23PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian CancerNew Mexico Cancer Research AlliancePhase 1/2 Active not recruiting50 enrolled